Clinical Trial Update: Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex [Phase 4]

View source ↗

Summary

Phase 4 open-label non-inferiority trial evaluating Xeomin in cervical dystonia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Cervical Dystonia | Phase 4 | Status: COMPLETED | Results posted: 2019-09-06